Published in Cancer Weekly, November 27th, 2007
G4544 is a new tablet formulation using delivery technology developed by Emisphere Technologies, Inc. that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.